FDA 483 - Sunsho Pharmaceutical Co., Ltd. - April 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sunsho Pharmaceutical Co., Ltd. in Fuji-shi, Shizuoka, Japan, a dietary supplement manufacturer, received a Form 483 with five observations. The inspection revealed significant deficiencies in establishing specifications for components and finished products, using scientifically valid testing methods, and maintaining complete batch and master manufacturing records. These issues indicate a lack of adequate controls to ensure the quality and identity of dietary supplements for the U.S. market.
ID · 780ad205-4cf6-49dd-bfb4-6292d2eaca8c